Tracers / [67Cu]Cu-FAPI-2286
[67Cu]Cu-FAPI-2286
Also written as [Cu-67]Cu-FAPI-2286
- Radionuclide
- Cu-67 t½ 3708 min
- Modality
- Therapy
- Production route
- —
- Stage
- —
- Syntheses indexed
- 0
What it is
- Compound class
- —
- Target / mechanism
- Fibroblast Activation Protein (FAP) PMID 42425054
- Clinical application
- Liver fibrosis (HCV-related decompensated cirrhosis with ascites) PMID 42425054
- Theranostic pair
- <a href="/tracers/cu64-fapi2286/">cu64-fapi2286</a>
Regulatory status
- FDA
- —
- EMA (centralised)
- —
- Other approvals
- —
- Brand names
- —
Clinical use
- Typical injected activity
- —
- Uptake time
- —
Reported in the literature. Not a dosing recommendation.
Published syntheses
No synthesis has been parsed for this agent yet.
Need this precursor?We can point you to suppliers for [67Cu]Cu-FAPI-2286, or handle the enquiry for you.
Get in touchNotes
Added at stage 21 from therapy-discovered.xlsx (bulk PubMed search by isotope/therapy-type/known-agent, not individually researched yet) -- 1 articles found. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty. Diagnostic pair signal at discovery: YES - Cu-64.